OPS.TO - Opsens Inc.

Toronto - Toronto Delayed Price. Currency in CAD
0.8700
-0.0100 (-1.14%)
At close: 10:26AM EDT
Stock chart is not supported by your current browser
Previous Close0.8800
Open0.8900
Bid0.8600 x N/A
Ask0.8800 x N/A
Day's Range0.8700 - 0.9000
52 Week Range0.6200 - 1.0200
Volume11,500
Avg. Volume44,389
Market Cap78.37M
Beta (3Y Monthly)0.83
PE Ratio (TTM)N/A
EPS (TTM)-0.0180
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.90
  • GlobeNewswire2 days ago

    UPDATE - Opsens Solutions Partners With Temai Ingenieros for the Commissioning of an Optical-Based Fuel Monitoring System for a Major Aircraft Manufacturer

    Opsens Inc. ("Opsens" or the "Company") (OPS.TO) (OTCQX:OPSSF) today announced that Opsens Solutions Inc. ("Opsens Solutions"), its wholly-owned subsidiary, is partnering with Temai Ingenieros S.L. ("Temai") for the commissioning of an optical-based fuel monitoring system for a major aircraft manufacturer. This agreement comes after over a year of development and ground testing of an aircraft fuel monitoring system based on Opsens Solutions’ fiber optic sensing technology.

  • CNW Group9 days ago

    Opsens Solutions Further Expands Intellectual Property Portfolio with USPTO Grant

    QUEBEC CITY , June 11, 2019 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (OPS.TO) (OPSSF) today announced that its wholly-owned subsidiary Opsens Solutions Inc. ("Opsens Solutions"), has been granted a patent for an innovative optical-based pressure sensor from the United States Patent and Trademark Office ("USPTO"). Patent no. 10,082,437 entitled "Optical Pressure Sensor with Reduced Mechanical Stresses" describes an innovative fiber optic pressure sensor design aimed at solving sensor drift, one of the most challenging problems encountered with sensors used in high pressure environments. Tested by a world-renowned, independent laboratory, this new fiber optic pressure sensor has shown unparalleled low-drift performances when measuring minute changes in differential pressure.

  • ACCESSWIRE29 days ago

    Opsens To Present at the LD Micro Invitational

    QUEBEC CITY, QC / ACCESSWIRE / May 22, 2019 / Opsens Inc. ("Opsens" or the "Company") (TSX: OPS) ( OTCQX: OPSSF ) , a company focusing mainly on physiological measurements such as Fractional ...

  • Some Opsens (TSE:OPS) Shareholders Are Down 35%
    Simply Wall St.last month

    Some Opsens (TSE:OPS) Shareholders Are Down 35%

    For many investors, the main point of stock picking is to generate higher returns than the overall market. But in any...

  • Opsens Signs Landmark Supplier Agreement - Expands Optical Sensing Technology Impact Within Cardiology Segment
    CNW Group2 months ago

    Opsens Signs Landmark Supplier Agreement - Expands Optical Sensing Technology Impact Within Cardiology Segment

    QUEBEC CITY , April 30, 2019 /CNW Telbec/ - Opsens inc. ("Opsens" or the "Company") (OPS.TO) (OPSSF) is pleased to announce it has entered into a supply agreement as part of its long-term collaboration with Abiomed, Inc. ("Abiomed") for the Impella CP® heart pump. Abiomed has awarded Opsens a five-year agreement to supply a critical component for its heart pump technology. This new agreement between Opsens and Abiomed follows a co-development and license agreement to integrate Opsens' miniature optical pressure sensor into Impella CP® heart pumps, signed in 2014.

  • Does Opsens Inc. (TSE:OPS) Have A Volatile Share Price?
    Simply Wall St.2 months ago

    Does Opsens Inc. (TSE:OPS) Have A Volatile Share Price?

    If you own shares in Opsens Inc. (TSE:OPS) then it's worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of volatility. Volatility is considered to be a measure of ris...

  • CNW Group2 months ago

    Opsens - Q2 2019 Revenues Reach $7.9 M, a 46% Increase

    Opsens - Q2 2019 Revenues Reach $7.9 M, a 46% Increase

  • Opsens Appoints Alan Milinazzo as Executive Chairman of the Board of Directors
    CNW Group4 months ago

    Opsens Appoints Alan Milinazzo as Executive Chairman of the Board of Directors

    QUEBEC CITY , March 4, 2019 /CNW Telbec/ - Opsens Inc. ("Opsens") (OPS.TO) (OPSSF) is pleased to announce the appointment of Mr. Alan Milinazzo as Executive Chairman of the Board of Directors. "We are delighted to see Alan, a renowned leader in the medical device industry, join us. Alan has had extensive success in building high-performance commercial teams in interventional cardiology.

  • CNW Group4 months ago

    Opsens announces credit agreement with CIBC Innovation Banking

    QUEBEC CITY , Feb. 27, 2019 /CNW Telbec/ - Opsens Inc. ("Opsens") (OPS.TO) (OPSSF) is pleased to announce that it has entered into an $8 M credit agreement (the "Agreement") with CIBC Innovation Banking (CIBC). "The Agreement offered carries excellent conditions. The Agreement consists of a $7 M term loan, set to mature in 60 months and of a $1 M revolving operating credit margin, set to mature in one year and that may be renewed on an annual basis.

  • Market Sentiment Around Loss-Making Opsens Inc. (TSE:OPS)
    Simply Wall St.4 months ago

    Market Sentiment Around Loss-Making Opsens Inc. (TSE:OPS)

    Opsens Inc.'s (TSE:OPS): Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. With the latest financialRead More...

  • Opsens - Election results for the Board of directors
    CNW Group5 months ago

    Opsens - Election results for the Board of directors

    Opsens - Election results for the Board of directors

  • ACCESSWIRE5 months ago

    Today's Research Reports on Espial Group, Opsens, EXFO and Ynvisible Interactive

    NEW YORK, NY / ACCESSWIRE / January 14, 2019 / The Market Edge strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us ...

  • Opsens - Q1 2019 revenues reach a record high of $9.1 M, a 43% increase
    CNW Group5 months ago

    Opsens - Q1 2019 revenues reach a record high of $9.1 M, a 43% increase

    Opsens - Q1 2019 revenues reach a record high of $9.1 M, a 43% increase

  • CNW Group5 months ago

    Opsens' dPR obtains CE marking to sell in Europe

    QUEBEC CITY , Jan. 9, 2019 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (OPS.TO) (OPSSF) has been granted CE marking for its diastolic pressure algorithm ("dPR"). Opsens' dPR algorithm has been designed to assess intracoronary pressure with the heart at rest to diagnose coronary disease without the injection of heart-stimulating medication. Opsens' diastolic pressure ratio will work in combination with the OptoWire and the OptoMonitor.

  • Is Opsens Inc.’s (TSE:OPS) CEO Pay Fair?
    Simply Wall St.5 months ago

    Is Opsens Inc.’s (TSE:OPS) CEO Pay Fair?

    Louis Laflamme has been the CEO of Opsens Inc. (TSE:OPS) since 2013. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar Read More...

  • ACCESSWIRE7 months ago

    Today's Research Reports on FLYHT Aerospace Solutions, AgJunction, Opsens and Engagement Labs

    NEW YORK, NY / ACCESSWIRE / November 30, 2018 / The Market Edge strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us ...

  • CNW Group7 months ago

    UPDATE - Opsens reports Q4 and FY2018 results

    UPDATE - Opsens reports Q4 and FY2018 results

  • CNW Group7 months ago

    Opsens receives Health Canada approval for dPR intended for the diagnosis of coronary stenosis with the heart at rest

    QUEBEC CITY , Nov. 27, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens") (OPS.TO) (OPSSF)  announced today that it has obtained approval from Health Canada to market its dPR Proprietary Resting Index,  which measures intracoronary pressure and establishes a diagnosis with the heart at rest to guide the treatment of patients with coronary heart disease. The measurement of Fractional Flow Reserve ("FFR") as a method of assessing intracoronary pressure is now the gold standard among medical professionals and has gained credibility and popularity following the publication of clinical studies demonstrating better clinical outcomes. Opsens' dPR has been developed to meet the demand by cardiologists for a way to measure intracoronary pressure with the heart at rest.

  • Do Institutions Own Opsens Inc (TSE:OPS) Shares?
    Simply Wall St.7 months ago

    Do Institutions Own Opsens Inc (TSE:OPS) Shares?

    The big shareholder groups in Opsens Inc (TSE:OPS) have power over the company. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership Read More...

  • Opsens - First use of dPR for the diagnosis of coronary stenosis with the heart at rest
    CNW Group7 months ago

    Opsens - First use of dPR for the diagnosis of coronary stenosis with the heart at rest

    QUEBEC CITY , Nov. 8, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens") (OPS.TO) (OPSSF) announces that its Diastolic Pressure Ratio called dPR, has been used for the first time by Dr. Hitoshi Matsuo, cardiologist and President of the Gifu Heart Center Japan. The measurement of Fractional Flow Reserve ("FFR") as a method of assessing intracoronary pressure has gained credibility and popularity following the publication of clinical studies demonstrating its benefits for patients' health. Opsens' dPR has been developed to answer the need cardiologists have expressed to measure intracoronary pressure to make a diagnosis with the heart at rest.

  • CNW Group8 months ago

    Opsens - 50,000 patients diagnosed with the OptoWire

    QUEBEC CITY , Nov. 1, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (OPS.TO) (OPSSF) has reached an important milestone with more than 50,000 patients assessed with the OptoWire™, a pressure guidewire used to measure Fractional Flow Reserve ("FFR") to diagnose and treat cardio vascular disease. As Societies of Cardiology are recommending expanding the use of pressure guidewires and physiology assessments, Opsens has scaled up manufacturing to respond to the growing demand for the OptoWire in its main markets, namely Japan , the United States , Europe and Canada , and to expand its reach to new geographies. "This milestone is a testament to the quality of our product, of our team and of our vision to take on the challenge to bring a second-generation fiber optic technology pressure guidewire to the market," said Louis Laflamme , President and CEO.

  • ACCESSWIRE8 months ago

    Today's Research Reports on Opsens, BTL Group, Venzee Technologies and Constellation Software

    NEW YORK, NY / ACCESSWIRE / October 29, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • CNW Group9 months ago

    Opsens - New product for the diagnosis of coronary stenosis with the heart at rest

    QUEBEC CITY , Sept. 20, 2018 /CNW Telbec/ - Opsens Inc. ("Opsens" or the "Company") (OPS.TO) (OPSSF) announces it has developed a product that will allow the diagnosis of coronary heart blockages with the heart at rest. Filing for regulatory approvals has been completed in targeted territories. Opsens plans to begin commercialization by the end of calendar year 2018.

  • ACCESSWIRE9 months ago

    Today's Research Reports on NexOptic Technology, Opsens, Good Life Networks and Neptune Dash Technologies

    NEW YORK, NY / ACCESSWIRE / September 19, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • When Will Opsens Inc (TSE:OPS) Turn A Profit?
    Simply Wall St.9 months ago

    When Will Opsens Inc (TSE:OPS) Turn A Profit?

    Opsens Inc’s (TSE:OPS): Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The CA$74.6m market-cap company’sRead More...